Internal Server Error

About Harbinger Venture Capital

Harbinger Venture Capital is a venture capital firm founded in 2000. It is primarily based out of Taipei, Taiwan. As of Oct 2025, Harbinger Venture Capital is an active investor, having invested in 65 companies, with 1 new investment in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series D round of xMEMS Overall, Harbinger Venture Capital portfolio has seen 1 unicorn, 17 IPOs and 16 acquisitions including key companies like VeriSilicon, Crown Bioscience and Applied Optoelectronics. A lot of funds co-invest with Harbinger Venture Capital, with names like IDG Capital sharing a substantial percentage of its portfolio. Harbinger Venture Capital has team of 13 people including 1 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Series B, Series A & 3 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months

Harbinger Venture Capital's List of Top Investments

Harbinger Venture Capital has a portfolio of 65 companies, one of which is a Unicorn. Their most notable investments are in Quintic and VeriSilicon.Their portfolio spans across Taiwan, United States and China. They have invested in Life Sciences, Enterprise Applications, High Tech and 22 other sectors, across stages such as Series B, Series A  and 3 more. Here is the list of top investments by Harbinger Venture Capital:
Provider of silicon platform-as-a-service which provides design solutions for SOC and SIPs. The company claims to use artificial intelligence and machine learning to cater to mobile internet devices, IoT, data centers, automotive, and medical electronics. The company has developed IPs such as a Vision Image Processor platform, a low-power GPU, an ultra-high-definition video codec, and a digital signal processing IP.

Key facts about VeriSilicon

Crown Bioscience develops drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases). The company’s proprietary platform includes HuPrime that is a patient-derived xenograft (PDX) models which can be used for efficacy testing. It also offers oncology services, such as oncology databases, ex vivo services, human surrogate trials, in vitro and in vivo services, preclinical models (PDX, Humanized and Murine efficacy/PD) for CAR-T Therapy Evaluation (immuno-oncology) etc., CrownBio also has a variety of rodent and mouse models for the development of drugs for CVMD. The company also offers products, such as antibodies for in vivo and in-vitro studies, tissues for CVMD research, tumor samples for Oncology R&D, cytokines and growth factors for use in basic and preclinical research, recombinant proteins and cell lines for biological studies, immune checkpoint antibodies and tumor tissue microarrays. CrownBio has strategic partnerships with Xstrahl, a designer, and manufacturer of X-Ray solutions for radiation biology research and Horizon Discovery, a provider of advanced research tools and services for the development of personalized medicines. CrownBio acquired PreClinOmics, an in vivo preclinical company specializing in CVMD and renal disease research. The company has spun-off CBT pharmacueticals, an emerging life science oncology company.

Key facts about Crown Bioscience

AOI is a manufacturer of fiber-optic networking products. It serves various markets such as cable television broadband, fiber-to-the-home, and internet data centers. It designs and manufactures various optical communications products employing their own vertical integration strategy from laser chips, components, subassemblies, and modules. It designs, manufactures, and integrates analog and digital lasers using a proprietary Molecular Beam Epitaxy (MBE) fabrication process.

Key facts about Applied Optoelectronics

  • Founded Year: 1997
  • Location: Sugar Land (United States)
  • Annual Revenue: $100M - $500M as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $90.5M
  • Employee Count: 604 as on Apr 30, 2026
  • Investors: Techlink Ventures, Giza Venture Capital and 5 Others
  • Latest Funding Round: Conventional Debt, Mar 05, 2019, $*****
  • Highlight: Public
Provider of application delivery, security, and centralized management and analytics solutions. The company offers solutions for application availability and acceleration, hybrid cloud application delivery and security, and IPv4 to IPv6 migration. It provides protection from network layer DDoS attacks, application layer attack prevention, and API protection. The company delivers centralized management for security and infrastructure solutions, enabling intelligent analytics, traffic visibility, and streamlined operations.

Key facts about A10 Networks

  • Founded Year: 2004
  • Location: United States
  • Annual Revenue: $100M - $500M as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $118M
  • Employee Count: 747 as on May 31, 2026
  • Investors: Sprout Capital Partners, Mitsui and 10 Others
  • Latest Funding Round: Post IPO, Jun 23, 2016, $*****
  • Highlight: Public
Provider of remote access and remote support software and solutions. The company delivers remote access for individuals and teams to access computers. It offers remote support for IT professionals to remotely support devices. Autonomous endpoint management is available for monitoring, managing, and securing devices. Enterprise-grade remote access and support with single sign-on and advanced manageability are also provided.

Key facts about Splashtop

Harbinger Venture Capital's Investments by Stage

Harbinger Venture Capital has made 7 investments in Series B stage with an average round size of $17.8M, 6 investments in Series A stage with an average round size of $7.12M, 2 investments in Series C stage with an average round size of $16.4M, 2 investments in Series D stage with an average round size of $84M and 1 investment in Series G stage with an average round size of $14.4M.
Here are Harbinger Venture Capital's investments by stage:
Stage of entry
No. of Investments
Series B
7
Series A
6
Series C
2
Series D
2
Series G
1
Breakdown of Harbinger Venture Capital's investments by stage of entrySeries B (7)Series A (6)
Note: We have considered here, only first round of investments

Harbinger Venture Capital's Investments by Sector

Harbinger Venture Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Semiconductors, Life Sciences, Enterprise Infrastructure and Telecom. Notably, it has invested in 40 Enterprise (B2B) companies, 38 Tech companies, 16 Software companies and at least 16 companies focusing on Tech hardware.
Here are Harbinger Venture Capital's investments by sector:
Sector
No. of Investments
Enterprise Applications
5
Semiconductors
5
Life Sciences
4
Enterprise Infrastructure
3
Telecom
2
Others
9
Breakdown of Harbinger Venture Capital's investments by sectorsEnterprise Applic... (5)Semiconductors (5)
Note: We have considered here, only first round of investments

Harbinger Venture Capital's Investments by Geography

Harbinger Venture Capital has made most investments in United States (15), followed by China where it has made 2 investments.
Here are Harbinger Venture Capital's investments by geography:
Country
No. of Investments
United States
15
China
2
Taiwan
1
Breakdown of Harbinger Venture Capital's investments by countriesUnited States (15)China (2)
Note: We have considered here, only first round of investments

Harbinger Venture Capital's recent investments

Harbinger Venture Capital has not made any investment in 2026 so far.
Here are the most recent investments by Harbinger Venture Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Oct 30, 2025
United States
Series D
3616
Mar 04, 2025
United States
Series B
3610
Jan 04, 2023
Taiwan
Series A
8313
Aug 20, 2014
United States
Series C
8180
  [+3]
Sep 19, 2011
United States
Series D
9955

Unicorns in Harbinger Venture Capital's Portfolio

Harbinger Venture Capital has 1 unicorn in its portfolio - Splashtop. The most recent unicorn in their portfolio is Splashtop which became a unicorn in 2021, 13 years after Harbinger Venture Capital first invested in it.
Here is a list of unicorns in Harbinger Venture Capital's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
66
Provider of remote access and remote support software and solutions
2006
San Jose
Series E
sojrea{

IPOs and Publicly Listed companies in Harbinger Venture Capital's Portfolio

17 of Harbinger Venture Capital's portfolio companies have become public. WHETRON got listed on the Taipei Stock Exchange (TT), in May 2023 and Chuangkong Technology got listed on the Taipei Stock Exchange (TT).
Here are Harbinger Venture Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
May 11, 2023
-
-
4272
Mar 30, 2023
-
-
8969
Dec 02, 2022
-
-
3610
Sep 08, 2022
-
-
1971
Dec 08, 2021
-
-
6931

Acquired companies in Harbinger Venture Capital's Portfolio

16 companies from Harbinger Venture Capital's portfolio have been acquired. The most recent acquisition was Crown Bioscience in Nov 2025 by Aidikang Medical Laboratory Center for $*****.
Here are Harbinger Venture Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Nov 13, 2025
-
-
7063
Jul 29, 2024
-
-
5217
Aug 23, 2023
-
-
2985
Jun 02, 2022
-
-
2577
Jun 01, 2021
Apr 02, 2007
Series B
6601

Team profile of Harbinger Venture Capital

Harbinger Venture Capital has a team of 13 members including 1 Partner and 5 Principals located in Taiwan and United States. Harbinger Venture Capital's team does not sit on the board of any company as of now.
Here is a list of top team members in Harbinger Venture Capital:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Taiwan
-
Principal
Taiwan
-
Principal
-
-
Principal
Taipei
-
Principal
Houston
-
Principal
Litchfield
-
-

Co-investors of Harbinger Venture Capital

Over the past 24 years, 107 investors have co-invested in Harbinger Venture Capital's portfolio companies. This includes funds and angels.

  • Invested before Harbinger Venture CapitalParagon Investments, Yuanda Financial Holdings and 12 others have invested in rounds before Harbinger Venture Capital. There is 1 company where Paragon Investments has invested before Harbinger Venture Capital and 1 company where Yuanda Financial Holdings has invested before Harbinger Venture Capital.
  • Top Co-investors of Harbinger Venture Capital50 investors entered a company along with Harbinger Venture Capital. These include investors like IDG Capital (3 companies).
  • Invested after Harbinger Venture CapitalA total of 43 investors have invested in Harbinger Venture Capital's portfolio after their investments. Top Investors include Austin Ventures (1 company), Sierra Ventures (1 company) and Legend Capital (1 company).

Recent News related to Harbinger Venture Capital

View all news related to Harbinger Venture Capital

FAQs about Harbinger Venture Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford